AQST-109 Shows Lower Systemic Exposure, Study Finds
AQST-109 maintained lower overall systemic exposure than reference products in recent clinical evaluations, according to data presented at a major scientific meeting.
AQST-109 maintained lower overall systemic exposure than reference products in recent clinical evaluations, according to data presented at a major scientific meeting.